A carregar...

Dexmedetomidine to Control Agitation and Delirium from Toxic Ingestions in Adolescents

Dexmedetomidine is an α(2)-adrenergic agonist that is approved by the Food and Drug Administration for the provision of short term (less than 24 hours) sedation of adults during mechanical ventilation. Given its beneficial physiologic effects including sedation and anxiolysis, various applications h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Tobias, Joseph D.
Formato: Artigo
Idioma:Inglês
Publicado em: Pediatric Pharmacy Advocacy Group 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3017407/
https://ncbi.nlm.nih.gov/pubmed/22477792
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!